Stay up-to-date with the latest announcements from the SGC.
Explore our official press releases to stay updated on our major accomplishments and new partnerships. Want to be the first to know about the latest news from SGC?
Explore our official press releases to stay updated on our major accomplishments and new partnerships. Want to be the first to know about the latest news from SGC?
Toronto, Canada & New York City, USA — The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington’s disease (HD) using structural and chemical biology…
Toronto, December 18, 2013 – Bayer Inc. is pleased to announce that Bayer HealthCare has joined the Structural Genomics Consortium (SGC), a not-for-profit, public-private partnership with active research facilities at the Universities of Toronto and Oxford, UK. Bayer will…
Toronto, ON (October 25, 2013) – The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.…